Concepedia

Publication | Open Access

Radium-223 Plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results

DOIFull Paper Access

28

Citations

9

References

2021

Year

Benjamin L. Maughan, Adam Kessel, Taylor Ryan McFarland, Nicolas Sayegh, Roberto Nussenzveig, Andrew W. Hahn, John M. Hoffman, Kathyrn Morton, Deepika Sirohi, Manish Kohli,
The Oncologist

Abstract

The combination of enzalutamide and radium-223 was found to be safe and associated with promising efficacy in men with mCRPC. These hypothesis-generating results portend well for the ongoing phase III PEACE III trial in this setting.

References

YearCitations

Page 1